- Home
- EOS vs BLFS Comparison
EOS vs BLFS Comparison
Compare EOS & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EOS | BLFS |
|---|---|---|
| Founded | N/A | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2004 | 2013 |
Fundamental Metrics
Financial Performance| Metric | EOS | BLFS |
|---|---|---|
| Price | $22.01 | $26.40 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $32.00 |
| AVG Volume (30 Days) | 131.5K | ★ 771.8K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.27 |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $96,214,000.00 |
| Revenue This Year | N/A | $19.73 |
| Revenue Next Year | N/A | $17.82 |
| P/E Ratio | ★ N/A | $1,334.50 |
| Revenue Growth | N/A | ★ 16.97 |
| 52 Week Low | $19.44 | $17.86 |
| 52 Week High | $24.49 | $29.57 |
Technical Indicators
Market Signals| Indicator | EOS | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 43.29 | 58.92 |
| Support Level | $21.73 | $23.60 |
| Resistance Level | $22.20 | $26.59 |
| Average True Range (ATR) | 0.34 | 1.35 |
| MACD | -0.09 | -0.13 |
| Stochastic Oscillator | 26.53 | 58.98 |
Price Performance
Historical ComparisonAbout EOS Eaton Vance Enhance Equity Income Fund II
Eaton Vance Enhanced Equity Income Fund II is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income, with a secondary objective of capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in common stocks. It invests in a portfolio of large and mid-cap securities in sectors such as Information Technology, Consumer Discretionary, Communication Services, Healthcare, Industrials, Consumer Staples, Financials, Materials, and Energy.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.